Information Provided By: 
Fly News Breaks for November 7, 2019
TMDX
Nov 7, 2019 | 08:18 EDT
Cowen analyst Joshua Jennings lowered his price target on Transmedics to $28 from $40. The analyst said he is still a a believer in the long-term transformative potential of its OCS system, but has tempered his intermediate growth assumptions to better reflect a degree of conservatism as the company ramps its three organ programs. Jennings said the weakness is a buying opportunity and he reiterated his Outperform rating on Transmedics shares.
News For TMDX From the Last 2 Days
There are no results for your query TMDX
